Prix Pharma

Sutinat 25mg (sunitinib) is a targeted cancer therapy used for advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST) resistant to other treatments, and pancreatic neuroendocrine tumors (pNET). It works as a tyrosine kinase inhibitor, blocking enzymes that promote cancer growth and blood supply (angiogenesis) to shrink tumors and slow disease progression. Treatment involves specific dosing schedules, often with cycles of daily use followed by breaks, and common side effects include fatigue, high blood pressure, nausea, and hand-foot syndrome.